Glenn F. Tilton - 03 May 2024 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
Director
Signature
T.O. Odutayo, Attorney-in-Fact for Glenn F. Tilton
Issuer symbol
ABBV
Transactions as of
03 May 2024
Net transactions value
$0
Form type
4
Filing time
07 May 2024, 18:30:22 UTC
Previous filing
18 Jan 2024
Next filing
17 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Award $0 +1,322 +2.7% $0.000000 50,361 03 May 2024 Direct F1
holding ABBV Common Stock, $0.01 par value 350 03 May 2024 By Wife F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
F2 The reporting person disclaims beneficial ownership of all securities held by his wife.